Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Myriad Genetics Breast Cancer Test Secures Coverage From Five BCBS Affiliates

Myriad Genetics Breast Cancer Test Secures Coverage From Five BCBS Affiliates

Jan 06, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Myriad Genetics announced today that it has received positive coverage determinations for its EndoPredict breast cancer test from five Blue Cross Blue Shield affiliate plans.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  2. JP Morgan Healthcare Conference 2021, Day One: Roche, Guardant, Hologic, Thermo Fisher, and More

  3. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  4. Report Details COVID-19 Testing Within Federal Government

  5. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.